A Regenerative Approach to Healing

Diabetes is more than just high blood sugar — it’s a chronic disease that damages blood vessels, nerves, and organs over time. In Thailand, over 5 million people live with diabetes, and many develop complications such as neuropathy, kidney disease, or chronic wounds. Today, regenerative medicine offers a promising new approach. At EDNA Wellness, we use umbilical-cord-derived mesenchymal stem cells (UC-MSCs) processed in TISTR GMP-certified laboratories to support healing, reduce inflammation, and improve tissue function.

Understanding Diabetes and Its Complications

There are two main types of diabetes:

• Type 1: Autoimmune destruction of insulin-producing β-cells in the pancreas.
• Type 2: Insulin resistance and gradual β-cell failure due to lifestyle and aging factors.

Common complications include:

• Diabetic neuropathy – nerve pain or numbness, often in feet or hands.
• Diabetic nephropathy – kidney damage leading to chronic renal failure.
• Diabetic retinopathy – vision loss from blood vessel damage in the eyes.
• Poor wound healing – especially foot ulcers that risk amputation.

Traditional management relies on insulin or oral medications, but these control symptoms rather than repair the underlying cellular damage.

How Stem Cells Can Help

Stem cells — especially UC-MSCs — can influence multiple mechanisms that directly address diabetic damage:

1. Pancreatic repair – promote regeneration of β-cells and insulin sensitivity (Zhao et al., 2024).
2. Vascular repair – secrete VEGF and FGF2 to restore microcirculation.
3. Anti-inflammatory effects – reduce TNF-α and IL-6 cytokines that cause chronic inflammation.
4. Nerve protection – support regeneration of damaged peripheral nerves.
5. Tissue healing – accelerate repair of diabetic wounds through collagen remodeling and angiogenesis.

These biological effects aim to stabilize metabolism, improve healing, and reduce progression of complications.

Scientific Evidence Supporting UC-MSC Therapy

• Clinical Trial (China, 2023): UC-MSC infusion improved insulin secretion and reduced HbA1c by 20 % in Type 2 diabetes (Li et al., 2023).
• From Analysis: MSC therapy reduced inflammatory markers and improved nerve function in diabetic neuropathy.
• Case Series (Thailand, 2024): Diabetic foot ulcers treated with UC-MSCs healed 40 % faster than standard care (Siriraj Regenerative Unit).

These findings suggest UC-MSC therapy is safe, well-tolerated, and biologically active against diabetic complications.

How Treatment Works at EDNA Wellness

Route	Purpose	Advantages
Intravenous (IV)	Systemic inflammation control	Non-invasive, supports whole-body repair
Local injection (e.g., foot or wound)	Targeted healing	Boosts local cell regeneration
Intrapancreatic (Research only)	Direct β-cell stimulation	Experimental, not standard clinical care

EDNA Wellness follows only clinically validated routes (IV + local) with GMP-certified UC-MSCs, ensuring sterility, viability, and correct dosage (≈ 1–2 × 10⁷ cells per session).

Safety and Oversight

• All UC-MSCs undergo sterility, endotoxin, and viability testing at TISTRlabs.
• No steroids, unverified mixtures, or genetic manipulation.
• No reported serious side effects — mild fatigue or headache may occur temporarily.
• Supervised by medical specialists in endocrinology and regenerative medicine.

This ensures complete transparency and patient safety under Thai FDA regenerative-medicine regulations.

Expected Clinical Benefits

Patients may experience:

• 1–3 months: Reduced inflammation, improved energy, and better glucose control.
• 3–6 months: Enhanced wound healing, sensation improvement in feet/hands.
• 6–12 months: Stable HbA1c and improved kidney or nerve function in responders.

UC-MSC therapy is not a cure but can complement medical management to slow and even reverse cellular-level damage.

Lifestyle Integration

Stem-cell therapy achieves the best outcomes when paired with lifestyle modification:

• Balanced diet with low-glycemic foods.
• Regular exercise to improve insulin sensitivity.
• Foot care and wound inspection routines.
• Adequate sleep and stress management.

EDNA Wellness provides integrated wellness programs combining nutrition, regenerative therapy, and follow-up assessments.

Cautions for Patients

• Verify your clinic’s GMP certification and doctor qualifications in regenerative medicine.
• Be cautious of marketing that promises “permanent diabetes cure.”
• Avoid facilities mixing low-dose cells with steroids or growth factors.
• Always continue prescribed diabetes medication under medical supervision.

EDNA Wellness promotes transparency, ethics, and data-driven results.

The Future of Diabetes Regeneration

Emerging research explores MSC-derived exosomes and gene-edited UC-MSCs that can release more insulin-promoting peptides. Collaborations between Thai and international institutions — including Mahidol University, TISTR, and NSTDA — are developing localized GMP biobanks to expand treatment access safely.

Stem-cell therapy offers a new frontier for diabetes care — one that targets the cellular roots of complications rather than symptoms. At EDNA Wellness, we apply this science responsibly through certified UC-MSC therapy, combining regenerative biology, medical supervision, and holistic care to improve health outcomes for diabetic patients.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Kim, J., Park, Y., & Choi, H. (2024). Mesenchymal stem-cell therapy for diabetic neuropathy: A meta-analysis of clinical outcomes. Frontiers in Endocrinology, 15, 212–225.*
• Li, M., Chen, Y., & Zhang, H. (2023). UC-MSC infusion improves β-cell function and insulin sensitivity in Type 2 diabetes: A phase II study. Stem Cell Research & Therapy, 14(2), 187–195.*
• Siriraj Regenerative Unit. (2024). Clinical outcomes of UC-MSCs in diabetic wound healing. Siriraj Medical Journal, 76(3), 310–318.*
• Zhao, L., Xu, J., & Wang, D. (2024). Umbilical-cord mesenchymal stem cells for diabetes: Mechanisms and therapeutic potential. Stem Cell Reviews and Reports, 20(4), 490–508.*